Does dual antiplatelet therapy increase the risk of haematoma enlargement in the acute stage? A retrospective study of the use of stent-assisted coiling versus coiling alone or balloon-assisted coiling for the treatment of ruptured intracranial aneurysms combined with intracranial haematoma.
Ruoxi Cheng, Kangtai Su, Xiaobing Zhou, Xin Jiang, Peiyi Luo, Weiyun Zhang, Xiao Qian, Lingfeng Lai
Author Information
Ruoxi Cheng: Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Kangtai Su: The First Clinical Medical School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Xiaobing Zhou: Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Xin Jiang: Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Peiyi Luo: Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Weiyun Zhang: Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Xiao Qian: Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Lingfeng Lai: Department of Neurosurgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. laiweiwei1986@163.com.
This study aims to identify the efficacy and safety of stent-assisted coiling (SAC) treatment of ruptured intracranial aneurysms (RIAs) combined with intracranial haematoma (ICH) compared to coiling alone or balloon-assisted coiling (non-SAC). A retrospective analysis of 54 consecutive patients receiving endovascular therapy from 2014 to 2020 was performed. The data collected included baseline characteristics, angiographic results, perioperative complications, immediate aneurysm occlusion, clinical outcomes, follow-up at discharge and after 6 months, hospitalisation costs, and inpatient length of stay. Patients were categorised into the SAC group and the non-SAC group. Univariate and multivariate logistic regression analyses were used to identify risk factors related to clinical outcomes. Of the 54 patients harbouring RIAs with ICH, 22 (40.74%) and 32 (59.26%) patients were subject to SAC and non-SAC treatments, respectively. Postoperative rebleeding (1 [4.5%] and 3 [9.3%] in SAC and non-SAC groups, respectively, p > 0.05) and Hunt-Hess grade (IV-V) lesions (13.6% vs. 40.6%, p = 0.067) did not differ between the two groups. In total, 10 (45.5%) patients treated with SAC received a Fisher scale score of 0-3 compared with 6 (18.8%) patients treated with non-SAC methods (p = 0.035). Compared with the non-SAC group (7/21.9%), the rate of wide-necked aneurysms was increased in the SAC group (11/50%) (p = 0.031). No differences in poor outcomes (mRS > 2) were noted between the SAC and non-SAC groups (p > 0.05). Multivariate analysis revealed that ischaemic complication events (p = 0.016) represent the only independent risk factor for adverse outcomes, and a trend towards unfavourable clinical outcomes was noted for patients who smoke (p = 0.087). SAC is a safe and efficient treatment for RIAs combined with ICH when dual antiplatelet therapy (DAPT) is used in the perioperative period. In addition, SAC should be preferentially used in wide-neck RIAs. Ischaemic complications are a risk factor for poor clinical outcomes. Given the small sample size and retrospective bias of this study, these findings should be further verified in a study with a larger sample size or a randomised controlled trial (RCT).
Abbed KM, Ogilvy CS (2003) Intracerebral hematoma from aneurysm rupture. Neurosurg Focus 15(4):E4
[DOI: 10.3171/foc.2003.15.4.4]
Hong Y, Wang YJ, Deng Z, Wu Q, Zhang JM (2014) Stent-assisted coiling versus coiling in treatment of intracranial aneurysm: a systematic review and meta-analysis. PLoS ONE 9(1):e82311
[DOI: 10.1371/journal.pone.0082311]
Zhou Y, Duan G, Zhang X, Yang PF, Fang YB, Li Q, Zhao R, Xu Y, Hong B, Huang QH, Liu JM (2020) Outcome and prognostic factors of ruptured middle cerebral artery aneurysms treated via endovascular approach: a single-center 11-year experience. World Neurosurg 133:e187–e196
[DOI: 10.1016/j.wneu.2019.08.189]
Ni H, Zhao LB, Liu S, Jia ZY, Cao YZ, Shi HB (2022) Intracranial hematoma following ruptured anterior communicating artery aneurysms: risk factors, outcome, and prognostic factors after management of coiling first. J Neurointerv Surg. 14(5):neurintsurg-2021–017506.
Zhao B, Tan X, Yang H, Zheng K, Li Z, Xiong Y, Zhong M, AMPAS study group (2017) Stent-assisted coiling versus coiling alone of poor-grade ruptured intracranial aneurysms: a multicenter study. J Neurointerv Surg 9(2):165–168
[DOI: 10.1136/neurintsurg-2016-012259]
Zuo Q, Yang P, Lv N, Huang Q, Zhou Y, Zhang X, Duan G, Wu Y, Xu Y, Hong B, Zhao R, Li Q, Fang Y, Zhao K, Dai D, Liu J (2018) Safety of coiling with stent placement for the treatment of ruptured wide-necked intracranial aneurysms: a contemporary cohort study in a high-volume center after improvement of skills and strategy. J Neurosurg 131(2):435–441
[DOI: 10.3171/2018.3.JNS172199]
Salem MM, Ravindran K, Enriquez-Marulanda A, Ascanio LC, Jordan N, Gomez-Paz S, Foreman PM, Ogilvy CS, Thomas AJ, Moore JM (2020) Pipeline embolization device versus stent-assisted coiling for intracranial aneurysm treatment: a retrospective propensity score-matched study. Neurosurgery 87(3):516–522
[DOI: 10.1093/neuros/nyaa041]
Ryu CW, Park S, Shin HS, Koh JS (2015) Complications in stent-assisted endovascular therapy of ruptured intracranial aneurysms and relevance to antiplatelet administration: a systematic review. AJNR Am J Neuroradiol 36(9):1682–1688
[DOI: 10.3174/ajnr.A4365]
Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, Khoury J (1996) The ABCs of measuring intracerebral hemorrhage volumes. Stroke 27(8):1304–1305
[DOI: 10.1161/01.STR.27.8.1304]
Zhang F, Li P, Zhang C, Wang L, Jing SQ (2017) The prognosis factors for endovascular coiling of aneurysm in patients with ruptured intracranial aneurysm. J Craniofac Surg 28(6):e535–e539
[DOI: 10.1097/SCS.0000000000003818]
Samaniego EA, Gibson E, Nakagawa D, Ortega-Gutierrez S, Zanaty M, Roa JA, Jabbour P, Hasan DM (2019) Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms. Stroke Vasc Neurol 4(1):36–42
[DOI: 10.1136/svn-2018-000192]
Cagnazzo F, Di Carlo DT, Petrella G, Perrini P (2020) Ventriculostomy-related hemorrhage in patients on antiplatelet therapy for endovascular treatment of acutely ruptured intracranial aneurysms. A meta-anal Neurosurg Rev 43(2):397–406
[DOI: 10.1007/s10143-018-0999-0]
Hudson JS, Nagahama Y, Nakagawa D, Starke RM, Dlouhy BJ, Torner JC, Jabbour P, Allan L, Derdeyn CP, Greenlee JDW, Hasan D (2018) Hemorrhage associated with ventriculoperitoneal shunt placement in aneurysmal subarachnoid hemorrhage patients on a regimen of dual antiplatelet therapy: a retrospective analysis. J Neurosurg 129(4):916–921
[DOI: 10.3171/2017.5.JNS17642]
Nagahama Y, Allan L, Nakagawa D, Zanaty M, Starke RM, Chalouhi N, Jabbour P, Brown RD, Derdeyn CP, Leira EC, Broderick J, Chimowitz M, Torner JC, Hasan D (2018) Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia. J Neurosurg 129(3):702–710
[DOI: 10.3171/2017.5.JNS17831]
Hudson JS, Prout BS, Nagahama Y, Nakagawa D, Guerrero WR, Zanaty M, Chalouhi N, Jabbour P, Dandapat S, Allan L, Ortega-Gutierrez S, Samaniego EA, Hasan D (2019) External ventricular drain and hemorrhage in aneurysmal subarachnoid hemorrhage patients on dual antiplatelet therapy: a retrospective cohort study. Neurosurgery 84(2):479–484
[DOI: 10.1093/neuros/nyy127]
Tai J, Liu J, Lv J, Huibin K, Hou Z, Yang J, Zhang H, Huang Q (2019) Risk factors predicting a higher grade of subarachnoid haemorrhage in small ruptured intracranial aneurysm (< 5 mm). Neurol Neurochir Pol 53(4):296–303
[DOI: 10.5603/PJNNS.a2019.0029]
Hammer A, Steiner A, Ranaie G, Yakubov E, Erbguth F, Hammer CM, Killer-Oberpfalzer M, Steiner H, Janssen H (2018) Impact of comorbidities and smoking on the outcome in aneurysmal subarachnoid hemorrhage. Sci Rep 8(1):12335
[DOI: 10.1038/s41598-018-30878-9]
Yang P, Zhao K, Zhou Y, Zhao R, Zhang L, Zhao W, Hong B, Xu Y, Huang Q, Krings T, Liu J (2015) Stent-assisted coil placement for the treatment of 211 acutely ruptured wide-necked intracranial aneurysms: a single-center 11-year experience. Radiology 276(2):545–552
[DOI: 10.1148/radiol.2015140974]
Yamane F, Ishihara S, Kohyama S, Kanazawa R, Ishihara H, Suzuki M, Araki R, Suzuki H, Satoh A (2012) Local thrombus formation at the coil-parent artery interface during endovascular coil embolization of cerebral aneurysms. J Neurol Surg A Cent Eur Neurosurg 73(6):358–368
[DOI: 10.1055/s-0032-1315794]
Ogata A, Suzuyama K, Ebashi R, Takase Y, Inoue K, Masuoka J, Yoshioka F, Nakahara Y, Abe T (2019) Association between extracranial internal carotid artery tortuosity and thromboembolic complications during coil embolization of anterior circulation ruptured aneurysms. Acta Neurochir (Wien) 161(6):1175–1181
[DOI: 10.1007/s00701-019-03903-7]
Qureshi AI, Sung GY, Razumovsky AY, Lane K, Straw RN, Ulatowski JA (2000) Early identification of patients at risk for symptomatic vasospasm after aneurysmal subarachnoid hemorrhage. Crit Care Med 28(4):984–990
[DOI: 10.1097/00003246-200004000-00012]
Hurth H, Steiner J, Birkenhauer U, Roder C, Hauser TK, Ernemann U, Tatagiba M, Ebner FH (2021) Relationship of the vascular territory affected by delayed cerebral ischemia and the location of the ruptured aneurysm in patients with aneurysmal subarachnoid hemorrhage. Neurosurg Rev 44(6):3479–3486
[DOI: 10.1007/s10143-021-01522-4]
Lee H, Perry JJ, English SW, Alkherayf F, Joseph J, Nobile S, Zhou LL, Lesiuk H, Moulton R, Agbi C, Sinclair J, Dowlatshahi D (2018) Clinical prediction of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage. J Neurosurg 1:1–8
Santillan A, Schwarz J, Boddu S, Gobin YP, Knopman J, Patsalides A (2019) Stent-assisted coil embolization of anterior communicating artery aneurysms using the LVIS Jr stent. Interv Neuroradiol 25(1):12–20
[DOI: 10.1177/1591019918798144]
Pierot L, Cognard C, Anxionnat R, Ricolfi F, CLARITY Investigators (2010) Ruptured intracranial aneurysms: factors affecting the rate and outcome of endovascular treatment complications in a series of 782 patients (CLARITY study). Radiology. 256(3):916–23
[DOI: 10.1148/radiol.10092209]
Kocur D, Paździora P, Przybyłko N, Kukier W, Baron J, Rudnik A (2020) Thromboembolism during coiling of intracranial aneurysms: predictors and clinical outcome. Wideochir Inne Tech Maloinwazyjne 15(2):319–328
[PMID: 32489493]
Li G, Xing H, Mao G, Cai J, Jin D, Tian Y, Zhang X, Zhao B (2022) Predictors of thromboembolic complications after stent-assisted coiling of acutely ruptured intracranial aneurysms: a retrospective multicenter study. Front Cardiovasc Med 9:922858
[DOI: 10.3389/fcvm.2022.922858]
Hwang G, Kim JG, Song KS, Lee YJ, Villavicencio JB, Suroto NS, Park NM, Park SJ, Jeong EA, Kwon OK (2014) Delayed ischemic stroke after stent-assisted coil placement in cerebral aneurysm: characteristics and optimal duration of preventative dual antiplatelet therapy. Radiology 273(1):194–201
[DOI: 10.1148/radiol.14140070]
Choi HH, Cho YD, Yoo DH, Lee SH, Yeon EK, Kang HS, Cho WS, Kim JE, Han MH (2019) Comparative analysis of coil embolization in posterior and anterior communicating artery aneurysms. J Neurointerv Surg 11(8):790–795
[DOI: 10.1136/neurintsurg-2018-014490]
Okamura K, Morofuji Y, Horie N, Izumo T, Sato K, Fujimoto T, Matsuo T (2021) Hematoma expansion unrelated to rebleeding in ruptured anterior cerebral artery aneurysms treated by early endovascular embolization. Surg Neurol Int 12:571
[DOI: 10.25259/SNI_816_2021]
Hokari M, Shimbo D, Asaoka K, Uchida K, Itamoto K (2018) Impact of antiplatelets and anticoagulants on the prognosis of intracerebral hemorrhage. J Stroke Cerebrovasc Dis 27(1):53–60
[DOI: 10.1016/j.jstrokecerebrovasdis.2017.05.016]
Camps-Renom P, Alejaldre-Monforte A, Delgado-Mederos R, Martínez-Domeño A, Prats-Sánchez L, Pascual-Goñi E, Martí-Fàbregas J (2017) Does prior antiplatelet therapy influence hematoma volume and hematoma growth following intracerebral hemorrhage? Results from a prospective study and a meta-analysis. Eur J Neurol 24(2):302–308
[DOI: 10.1111/ene.13193]
Liu CH, Wu YL, Hsu CC, Lee TH (2023) Early antiplatelet resumption and the risks of major bleeding after intracerebral hemorrhage. Stroke 54(2):537–545
[DOI: 10.1161/STROKEAHA.122.040500]
Murthy S, Roh DJ, Chatterjee A, McBee N, Parikh NS, Merkler AE, Navi BB, Falcone GJ, Sheth KN, Awad I, Hanley D, Kamel H, Ziai WC; CLEAR III, MISTIE III and VISTA-ICH Collaborators (2020) Prior antiplatelet therapy and haematoma expansion after primary intracerebral haemorrhage: an individual patient-level analysis of CLEAR III, MISTIE III and VISTA-ICH. J Neurol Neurosurg Psychiatry. 2020 jnnp-2020–323458
van Ginneken V, Engel P, Fiebach JB, Audebert HJ, Nolte CH, Rocco A (2018) Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage. Neurol Sci 39(4):745–748
[DOI: 10.1007/s10072-018-3255-z]
Ducruet AF, Hickman ZL, Zacharia BE, Grobelny BT, DeRosa PA, Landes E, Lei S, Khandji J, Gutbrod S, Connolly ES Jr (2010) Impact of platelet transfusion on hematoma expansion in patients receiving antiplatelet agents before intracerebral hemorrhage. Neurol Res 32(7):706–710
[DOI: 10.1179/174313209X459129]
Goertz L, Liebig T, Pennig L, Timmer M, Styczen H, Grunz JP, Lichtenstein T, Schlamann M, Kabbasch C (2021) Propensity score-adjusted analysis on stent-assisted coiling versus coiling alone for ruptured intracranial aneurysms. Sci Rep 11(1):21742
[DOI: 10.1038/s41598-021-01156-y]
Zhang X, Zuo Q, Tang H, Xue G, Yang P, Zhao R, Li Q, Fang Y, Xu Y, Hong B, Huang Q, Liu J (2019) Stent assisted coiling versus non-stent assisted coiling for the management of ruptured intracranial aneurysms: a meta-analysis and systematic review. J Neurointerv Surg 11(5):489–496
[DOI: 10.1136/neurintsurg-2018-014388]
Abla AA, Wilson DA, Williamson RW, Nakaji P, McDougall CG, Zabramski JM, Albuquerque FC, Spetzler RF (2014) The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial. J Neurosurg 120(2):391–397
[DOI: 10.3171/2013.10.JNS13419]
Harrod CG, Bendok BR, Batjer HH (2005) Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery. 56(4):633–54; discussion 633–54.
Grants
20195115/Health Commission of Jiangxi Province
20195115/Health Commission of Jiangxi Province
20195115/Health Commission of Jiangxi Province
20195115/Health Commission of Jiangxi Province
20195115/Health Commission of Jiangxi Province
20195115/Health Commission of Jiangxi Province
20195115/Health Commission of Jiangxi Province
20195115/Health Commission of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province
20192BAB215024/Natural Science Foundation of Jiangxi Province